A Long-Term Study of Prognosis in Monoclonal Gammopathy of Undetermined Significance

Robert A. Kyle, Terry M. Therneau, S. Vincent Rajkumar, Janice R. Offord, Dirk R. Larson, Matthew F. Plevak

New England Journal of Medicine · 2002 · 1.5K citations · 14 references

Abstract

The risk of progression of MGUS to multiple myeloma or related disorders is about 1 percent per year.

References

14